🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a research study of SABER® -Bupivacaine, an experimental medication...
Status
Completed
Location
Durect Study Site 04
Start Date
2015-11
Trial ID
NCT02574520
Treatments Being Tested
This is a research study testing SABER-Bupivacaine (an experimental pain-re...
Status
Completed
Location
DURECT Study Site
Start Date
2009-12
Trial ID
NCT01052012
Treatments Being Tested
This is a research study testing SABER-Bupivacaine (an experimental pain-re...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00818363
Treatments Being Tested
The objective is to identify the optimal dose of SABER-Bupivacaine for post...
Status
Completed
Location
Nycomed
Start Date
2009-05
Trial ID
NCT00993226
The objective is to identify the optimal dose of SABER-Bupivacaine for post...
Status
Completed
Location
Nycomed Investigational Site
Start Date
2009-04
Trial ID
NCT00993798
The Center for Disease Control (CDC) and World Health Organization (WHO) ha...
Status
Completed
Location
University of Louisville
Start Date
2020-10-27
Trial ID
NCT04811339
This is a research study testing SABER-Bupivacaine (an experimental pain-re...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00974350
Treatments Being Tested
In this double-blind phase II randomized controlled trial, patients with lu...
Status
Recruiting
Location
BC-Cancer Agency - Vancouver
Start Date
2025-01-07
Trial ID
NCT05986318
This is an extension to a previous research trial testing SABER™-Bupivacain...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01139866